The study also highlights the depletion of USP5 as a stimulus for the transfer of IFN-I signaling from tumor cells to macrophages, thus reprogramming macrophages to IFN-I–responsive cells with potent antitumor activity (Figure 9), which enhances radiotherapy efficacy. The gene discussed is USP5; the disease is neoplasm.